Skip Navigation LinksHome > October 2013 - Volume 34 - Issue 10 > UK audit of quantification of left-ventricular function usin...
Nuclear Medicine Communications:
doi: 10.1097/MNM.0b013e328363f86d
Original Articles

UK audit of quantification of left-ventricular function using gated myocardial perfusion imaging

Cade, Sarah C.a; Hall, David O.b; Kenny, Bobc; Knight, Andyd; Lawson, Richard S.e; Livieratos, Lefterisf; Nijran, Kuldip S.g; White, Duncanh; on behalf of the Institute of Physics and Engineering in Medicine Nuclear Medicine Software Quality Group

Collapse Box


Purpose: The aim of the study was to evaluate UK-wide interinstitutional reproducibility of left-ventricular functional parameters, end-systolic volume, end-diastolic volume and ejection fraction, obtained from gated myocardial perfusion imaging (GMPI) studies using technetium-99m-labelled radiopharmaceuticals. The study was carried out by the UK Institute of Physics and Engineering in Medicine Nuclear Medicine Software Quality Group.

Materials and methods: Ten anonymized clinical GMPI studies, five with normal perfusion and five with perfusion defects, were made available in DICOM and proprietary formats for download and through manufacturers’ representatives. Two of the studies were duplicated in order to assess intraoperator repeatability, giving a total of 12 studies. Studies were made available in 8 and 16 frames/cycle.

Results: A total of 58 institutions across England, Scotland, Wales and Northern Ireland participated in this study using six different computer packages. Studies were processed at centres using their normal clinical computers and software. The overall mean±SD ejection fraction for all centres was 58.5±3%; the mean end-diastolic volume was 114±12 ml and the mean end-systolic volume was 54±6 ml. The results were affected by the number of frames per cycle and by the postprocessing computer package, but not by the reconstruction filter in the filtered back-projection.

Conclusion: Calculation of functional parameters from GMPI using technetium-99m-labelled radiopharmaceuticals is reliable and shows limited variability across the UK.

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.